Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Tianeptine may help prevent hair loss by promoting hair growth and reducing cell death.

Ritlecitinib helps hair regrowth and reduces emotional and functional burdens in alopecia areata.

Certain topical drugs can regrow hair in mice.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Keratinocyte growth factor promotes hair growth and reduces hair loss from chemotherapy.

Erlotinib can cause nonscarring hair loss and itchy skin.

Baricitinib significantly regrows hair in severe alopecia areata patients.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

A JAK1 variant causes hair loss, skin issues, and thyroid disease, but treatment with a specific inhibitor can help.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Baricitinib may effectively treat lichen planopilaris.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

Dual-targeting therapies like Janus kinase inhibitors may treat both alopecia areata and other immune diseases.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

Folliculin slows hair growth, and blocking it might help treat hair loss.

Ruxolitinib helps regrow hair in alopecia areata by blocking inflammation, reducing stress, and controlling cell death.

Baricitinib might help treat hair loss in lupus patients, but more research is needed.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

New drugs and therapies targeting specific pathways show promise in treating advanced prostate cancer.